Free Review Articles on Arthritis (rheumatoid)                                 Metatextbook

Freie Reviews über Arthritis (rheumatoide)                                 Look here for Journal Homepages

  • Arthritis (rheumatoid)
  • Tocilizumab
  • Rituximab
  • Psoriasis
  • Ustekinumab
  • Infliximab
  • Anakinra
  • Proteus spp
  • Methotrexate
  • Osteoarthritis
  • Abatacept
  • Endothelium
  • Dendritic cell (Immunology)
  • Regulatory T cell
  • Bone (MRT)
  • Interleukin18
  • Fibroblast
  • Systemic lupus erythematosus
  • Autoantibodies Anti CCP
  • T cell (Th17)
  • RNA (MicroRNA)
  • Clinical Examination (Musculoskeletal system)
  • Lung (Diseases interstitial)
  • Cholinergergic antiinflammatory pathway
  • Receptor (Acetylcholine nicotinic)
  • Bartonella henselae
  • Candida (BASKET)
  • Coccidioidomycosis
  • Ovary (Neoplasia)
  • Gastrointestinal stromal cell tumor GIST
  • Histoplasmosis
  • Testis (Neoplasia)
  • Lymphoma (Hodgkin)
  • Calcium (Hypercalciemia)
  • Cryptococcosis
  • Langerhans cell histiocytosis
  • Liver (Diseases)
  • Lepra
  • Lung (Neoplasm)
  • Lymphoma (BASKET)
  • Crohn s disease
  • Mycobacterium avium
  • Sarcoidosis
  • Tuberculosis
  • Wegener s granulomatosis
  • Pneumocystis carinii Pneumocystis jirovicii
  • Paracoccoidomycosis
  • Bacillus calmette guerin
  • Pseudolymphom (Lymphomatoid granulomatosis)
  • Lipoid Pneumonia
  • Lung (Toxicology)
  • Polymyositis
  • Silicone
  • Slack skin disease
  • Fat necrosis subcutaneous of the newborn
  • Pseudolymphoma (Plasma cell granuloma)
  • Testis (Neoplasia Seminoma)
  • Glutamate (Mediator non neuronal)
  • Calreticulin
  • SE (rheumatoid arthritis shared epitope)
  • Interleukin7
  • Fractalkine
  • Hand and wrist (Traumatology)
  • Certolizumab pegol
  • Fibroblast like synoviocytes
  • Estrogen
  • Histone deacetylase
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12006Treatment of rheumatoid arthritis.



    		+-nlBMJ 332(7534):152-5 (2006) Emery P
    21995ABC of rheumatology. Rheumatoid arthritis--II: Treatment.



    		+-nlBMJ 310(6980):652-5 (1995)
    31995ABC of rheumatology. Rheumatoid arthritis--I: Clinical features and diagnosis.



    		+-nlBMJ 310(6979):587-90 (1995)
    41993Medical management of rheumatoid arthritis.



    		+-nlBMJ 307(6901):425-8 (1993)
    51979Fifty years of gold in rheumatoid arthritis.



    		+-nlBr Med J 1(6159):289-90 (1979)
    62010Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis.



    		+-nlKorean J Intern Med 25(1):1-17 (2010) Storage SS
    71993Approach to initial medical treatment of rheumatoid arthritis.



    		+-nlArch Fam Med 2(5):545-51 (1993)
    82004Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know.



    		+-nlJ R Soc Med 97(9):421-4 (2004) Suresh E
    91996Managing early presentation of rheumatoid arthritis. Systematic overview.



    		+-nlCan Fam Physician 42():913-22 (1996) Glazier R
    102008Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.



    		+-nlBr J Clin Pharmacol 66(2):173-8 (2008) Sizova L
    112008Review of tocilizumab in the treatment of rheumatoid arthritis.



    		+-nlBiologics 2(1):75-82 (2008) Okuda Y
    122007Targeted therapies in rheumatoid arthritis: Focus on rituximab.



    		+-nlBiologics 1(4):325-33 (2007) Teng YK
    132010Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.



    		+-nlJ Manag Care Pharm 16(6):402-16 (2010) Schafer JA
    142006Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.



    		+-nlJ Manag Care Pharm 12(7):555-69 (2006) Doan QV
    152010Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.



    		+-nlTher Clin Risk Manag 6():143-52 (2010) Hushaw LL
    162007A systematic review of infliximab in the treatment of early rheumatoid arthritis.



    		+-nlTher Clin Risk Manag 3(5):905-11 (2007) Du Pan SM
    172006A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.



    		+-nlHealth Technol Assess 10(42):iii-iv, xi-xiii, 1-229 (2006) Chen YF
    182004The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.



    		+-nlHealth Technol Assess 8(18):iii-iv, ix-x, 1-105 (2004) Clark W
    192006Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection.



    		+-nlClin Dev Immunol 13(1):41-8 (2006) Ebringer A
    201999Dendritic cells and the pathogenesis of rheumatoid arthritis.



    		+-nlJ Leukoc Biol 66(2):286-92 (1999)
    212009A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis.



    		+-nlScand J Immunol 70(4):337-44 (2009) Wiens A
    222005New therapies for rheumatoid arthritis.



    		+-nlClin Exp Immunol 140(2):195-204 (2005) Goldblatt F
    232007Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience.



    		+-nlAngiogenesis 10(4):243-58 (2007) Khong TL
    241998Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target.



    		+-nlAngiogenesis 2(4):295-307 (1998)
    252009Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.



    		+-nlAnn Rheum Dis 68(7):1100-4 (2009) Salliot C
    262009Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis.



    		+-nlAnn Rheum Dis 68(7):1105-12 (2009) Katchamart W
    272009Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.



    		+-nlAnn Rheum Dis 68(7):1086-93 (2009)
    282009Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.



    		+-nlAnn Rheum Dis 68(7):1094-9 (2009)
    292008The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.



    		+-nlAnn Rheum Dis 67(7):909-16 (2008) Schett G
    302006Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.



    		+-nlAnn Rheum Dis 65(10):1373-8 (2006) Fransen J
    312006Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.



    		+-nlAnn Rheum Dis 65(1):45-50 (2006) Le Loet X
    322004What precedes development of rheumatoid arthritis?



    		+-nlAnn Rheum Dis 63 Suppl 2():ii28-ii31 (2004) Klareskog L
    332004Appropriate and effective management of rheumatoid arthritis.



    		+-nlAnn Rheum Dis 63(6):627-33 (2004) Breedveld FC
    342003Angiogenesis as a target in rheumatoid arthritis.



    		+-nlAnn Rheum Dis 62 Suppl 2():ii60-7 (2003) Koch AE
    352001"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.



    		+-nlAnn Rheum Dis 60 Suppl 3(-):iii51-4 (2001)
    362000The final pathogenetic steps in focal bone erosions in rheumatoid arthritis.



    		+-nlAnn Rheum Dis 59 Suppl 1(-):i72-4 (2000)
    372000The role of angiogenesis in rheumatoid arthritis: recent developments.



    		+-nlAnn Rheum Dis 59 Suppl 1(-):i65-71 (2000)
    381999Rheumatoid arthritis: a synovial disease?



    		+-nlAnn Rheum Dis 58(12):727-30 (1999)
    391993Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?



    		+-nlAnn Rheum Dis 52(6):423-8 (1993)
    401993Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?



    		+-nlAnn Rheum Dis 52 Suppl 1(-):S39-47 (1993)
    411993A reappraisal of the evidence that rheumatoid arthritis and several other idiopathic diseases are slow bacterial infections.



    		+-nlAnn Rheum Dis 52 Suppl 1(-):S30-8 (1993)
    421992Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.



    		+-nlAnn Rheum Dis 51(7):919-25 (1992)
    431992Local immune responses in certain extra-articular manifestations of rheumatoid arthritis.



    		+-nlAnn Rheum Dis 51(5):698-701 (1992)
    441988Synovial lining cell hyperplasia in rheumatoid arthritis: dogma and fact.



    		+-nlAnn Rheum Dis 47(4):348-9 (1988)
    451982Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities.



    		+-nlAnn Rheum Dis 41 Suppl 1(-):44-7 (1982)
    461981Heberden Oration 1980: aspects of the cell biology of the rheumatoid synovial lesion.



    		+-nlAnn Rheum Dis 40(5):433-48 (1981)
    471970Heberden Oration, 1969. Rheumatoid arthritis--nature or nurture?



    		+-nlAnn Rheum Dis 29(4):357-79 (1970)
    481962Femoral Head Destruction in Rheumatoid Arthritis and Osteo-Arthritis: A Clinical Review of 27 Cases.



    		+-nlAnn Rheum Dis 21(1):23-30 (1962)
    491960The Experimental Production of Arthritis: A Review.



    		+-nlAnn Rheum Dis 19(4):297-317 (1960)
    502009Developments in the scientific understanding of rheumatoid arthritis.



    		+-nlArthritis Res Ther 11(5):249 (2009) Goronzy JJ
    512008Abatacept in the treatment of rheumatoid arthritis.



    		+-nlArthritis Res Ther 10 Suppl 1():S5 (2008) Buch MH
    522008High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?



    		+-nlArthritis Res Ther 10(4):210 (2008)
    532007Cells of the synovium in rheumatoid arthritis. Chondrocytes.



    		+-nlArthritis Res Ther 9(5):220 (2007) Otero M
    542007Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.



    		+-nlArthritis Res Ther 9 Suppl 2():S3 (2007) Koch AE
    552007Cells of the synovium in rheumatoid arthritis. B cells.



    		+-nlArthritis Res Ther 9(2):205 (2007) Mauri C
    562007Cells of the synovium in rheumatoid arthritis. Osteoclasts.



    		+-nlArthritis Res Ther 9(1):203 (2007) Schett G
    572007Cells of the synovium in rheumatoid arthritis. T lymphocytes.



    		+-nlArthritis Res Ther 9(1):202 (2007) Lundy SK
    582007Mesenchymal stromal cells. Nurse-like cells reside in the synovial tissue and bone marrow in rheumatoid arthritis.



    		+-nlArthritis Res Ther 9(1):201 (2007) Ochi T
    592006What is MRI bone oedema in rheumatoid arthritis and why does it matter?



    		+-nlArthritis Res Ther 8(6):222 (2006) McQueen FM
    602006Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity.



    		+-nlArthritis Res Ther 8(4):216 (2006) van der Helm-van Mil AH
    612006Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register.



    		+-nlArthritis Res Ther 8(4):214 (2006)
    622006Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?



    		+-nlArthritis Res Ther 8(3):211 (2006) Machold KP
    632005Rheumatoid arthritis as a hyper-endoplasmic-reticulum-associated degradation disease.



    		+-nlArthritis Res Ther 7(5):181-6 (2005) Yamasaki S
    642005Regulatory T cells in rheumatoid arthritis.



    		+-nlArthritis Res Ther 7(3):93 (2005) Leipe J
    652004Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky.



    		+-nlArthritis Res Ther 6(2):60-72 (2004) Middleton J
    662003The value of sensitive imaging modalities in rheumatoid arthritis.



    		+-nlArthritis Res Ther 5(5):210-3 (2003) Taylor PC
    672009Developments in the clinical understanding of rheumatoid arthritis.



    		+-nlArthritis Res Ther 11(1):204 (2009) Smolen JS
    681999Rheumatoid arthritis: a review and suggested dental care considerations.



    		+-nlJ Am Dent Assoc 130(5):689-98 (1999)
    692008Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.



    		+-nlAnn Intern Med 148(2):124-34 (2008) Donahue KE
    701989The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.



    		+-nlPostgrad Med J 65(770):905-12 (1989)
    712002The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.



    		+-nlArthritis Res 4(5):281-9 (2002)
    722008Recent developments in the immunobiology of rheumatoid arthritis.



    		+-nlArthritis Res Ther 10(2):204 (2008) Andersson AK
    732003Understanding the window of opportunity concept in early rheumatoid arthritis.



    		+-nlArthritis Rheum 48(7):1771-4 (2003) Boers M
    742000The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.



    		+-nlArthritis Rheum 43(12):2619-33 (2000)
    752006Synovial fibroblasts: key players in rheumatoid arthritis.



    		+-nlRheumatology (Oxford) 45(6):669-75 (2006) Huber LC
    762003Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.



    		+-nlRheumatology (Oxford) 42 Suppl 2():ii11-6 (2003) Goldring SR
    772001The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?



    		+-nlRheumatology (Oxford) 40(11):1211-20 (2001)
    782000Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis.



    		+-nlRheumatology (Oxford) 39 Suppl 1(-):9-16 (2000)
    792007Early rheumatoid arthritis: a review of MRI and sonographic findings.



    		+-nlAJR Am J Roentgenol 189(6):1502-9 (2007) Boutry N
    802005Rheumatoid arthritis: a practical guide to state-of-the-art imaging, image interpretation, and clinical implications.



    		+-nlRadiographics 25(2):381-98 (2005) Sommer OJ
    812010Tocilizumab - a new step in rheumatoid arthritis treatment.



    		+-nlActa Reumatol Port 35(3):302-12 (2010)
    822008Dendritic cell subsets: their roles in rheumatoid arthritis.



    		+-nlActa Reumatol Port 33(1):35-45 (2008)
    832008Tregs and rheumatoid arthritis.



    		+-nlActa Reumatol Port 33(1):17-33 (2008)
    842010EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.



    		+-nlAnn Rheum Dis 69(6):964-75 (2010)
    852011Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.



    		+-nlAnn Rheum Dis 70(6):909-20 (2011)
    862003Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.



    		+-nlAnn Rheum Dis 62(8):722-7 (2003)
    872007Amplifying elements of arthritis and joint destruction.



    		+-nlAnn Rheum Dis 66 Suppl 3(-):iii45-8 (2007)
    882007A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis.



    		+-nlAnn Rheum Dis 66(12):1549-52 (2007)
    892007QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.



    		+-nlAnn Rheum Dis 66(11):1491-6 (2007)
    902007The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.



    		+-nlAnn Rheum Dis 66(11):1473-8 (2007)
    912007Cellular targets of interleukin-18 in rheumatoid arthritis.



    		+-nlAnn Rheum Dis 66(11):1411-8 (2007)
    922007Actin cytoskeleton dynamics linked to synovial fibroblast activation as a novel pathogenic principle in TNF-driven arthritis.



    		+-nlAnn Rheum Dis 66 Suppl 3(-):iii23-8 (2007)
    932005X linked agammaglobulinaemia and rheumatoid arthritis.



    		+-nlAnn Rheum Dis 64(7):1075-8 (2005)
    942002Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value.



    		+-nlArthritis Res 4(2):87-93 (2002)
    952003Roles of B cells in rheumatoid arthritis.



    		+-nlArthritis Res Ther 5 Suppl 4(-):S1-6 (2003)
    962003Targeting B cells for the treatment of rheumatoid arthritis.



    		+-nlArthritis Res Ther 5 Suppl 4(-):S7-11 (2003)
    972010Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.



    		+-nlArthritis Res Ther 12(3):210 (2010)
    982010The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.



    		+-nlArthritis Res Ther 12(1):203 (2010)
    992010Vasculogenesis in rheumatoid arthritis.



    		+-nlArthritis Res Ther 12(2):110 (2010)
    1002007Cells of the synovium in rheumatoid arthritis. Dendritic cells.



    		+-nlArthritis Res Ther 9(4):219 (2007)
    1012009Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review.



    		+-nlArthritis Res Ther 11 Suppl 1(-):S1 (2009)
    1022009Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.



    		+-nlArthritis Res Ther 11(1):201 (2009)
    1032008Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium.



    		+-nlArthritis Res Ther 10 Suppl 1(-):S2 (2008)
    1042008Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets.



    		+-nlArthritis Res Ther 10(2):205 (2008)
    1052010The American College of Rheumatology/European League Against Rheumatism criteria for the classification of rheumatoid arthritis: a game changer.



    		+-nlArthritis Rheum 62(9):2592-4 (2010) Cohen S
    1062010The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.



    		+-nlArthritis Rheum 62(9):2582-91 (2010)
    1072004The synovium in rheumatoid arthritis: evidence for (at least) two pathologies.



    		+-nlArthritis Rheum 50(1):1-4 (2004)
    1082009Getting them even earlier: Identifying individuals before clinical presentation with rheumatoid arthritis.



    		+-nlArthritis Rheum 61(12):1620-2 (2009) Liao KP
    1092003Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.



    		+-nlArthritis Rheum 48(3):594-601 (2003)
    1102010Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.



    		+-nlArthritis Rheum 62(10):2852-63 (2010)
    1112009Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need?



    		+-nlArthritis Rheum 60(4):912-5 (2009)
    1122009Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.



    		+-nlArthritis Rheum 61(5):704-10 (2009)
    1132008Pathophysiology of rheumatoid arthritis: split or lump?



    		+-nlArthritis Rheum 58(10):2925-7 (2008) Boers M
    1142008American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.



    		+-nlArthritis Rheum 59(6):762-84 (2008)
    1152008Lymphoid follicles in joints: what do they mean?



    		+-nlArthritis Rheum 58(6):1563-5 (2008)
    1162009Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.



    		+-nlArthritis Rheum 60(9):2558-64 (2009) Suarez-Gestal M
    11720081958 revision of diagnostic criteria for rheumatoid arthritis.



    		+-nlArthritis Rheum 58(2 Suppl):S15-9 (2008)
    1182010Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals.



    		+-nlAm J Manag Care 16(9 Suppl):S249-58 (2010)
    1192010Preventing the progression from undifferentiated arthritis to rheumatoid arthritis: the clinical and economic implications.



    		+-nlAm J Manag Care 16(9 Suppl):S243-8 (2010)
    1202003Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate.



    		+-nlAm J Manag Care 9(6 Suppl):S136-43 (2003)
    1212008Patients with suspected rheumatoid arthritis should be referred early to rheumatology.



    		+-nlBMJ 336(7637):215-6 (2008)
    1222006Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires.



    		+-nlBull NYU Hosp Jt Dis 64(1-2):32-9 (2006)
    1232006The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases.



    		+-nlBull NYU Hosp Jt Dis 64(1-2):20-4 (2006)
    1242006The pathogenesis of rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 64(1-2):12-5 (2006)
    1252010T-cell agents in the treatment of rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 68(3):162-5 (2010)
    1262010Anti-interleukin-6 therapy in rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 68(3):211-7 (2010)
    1272007Interleukin-6 in the pathogenesis of rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 65 Suppl 1(-):S4-10 (2007)
    1282007Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registries.



    		+-nlBull NYU Hosp Jt Dis 65(2):139-42 (2007)
    1292007Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 65 Suppl 1(-):S11-5 (2007)
    1302007Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.



    		+-nlBull NYU Hosp Jt Dis 65 Suppl 1(-):S16-20 (2007)
    1312009Monitoring response to therapy in rheumatoid arthritis - perspectives from the clinic.



    		+-nlBull NYU Hosp Jt Dis 67(2):236-42 (2009)
    1322008Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 66(3):216-23 (2008)
    1332008Emerging therapeutics for rheumatoid arthritis.



    		+-nlBull NYU Hosp Jt Dis 66(3):210-5 (2008)
    1342009Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.



    		+-nlChest 136(5):1397-405 (2009)
    1352008Radiographic evaluation of arthritis: inflammatory conditions.



    		+-nlRadiology 248(2):378-89 (2008)
    1362010New therapeutic approaches for the treatment of rheumatoid arthritis may rise from the cholinergic anti-inflammatory pathway and antinociceptive pathway.



    		+-nlScientificWorldJournal 10(-):2248-53 (2010)
    1372011Painful rheumatoid arthritis.



    		+-nlPain Physician 14(5):E427-58 (2011)
    1382010Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.



    		+-nlJ Clin Endocrinol Metab 95(7):3111-7 (2010)
    1392011Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis.



    		+-nlJ Pharmacol Sci 116(3):248-56 (2011)
    1402010A role for calreticulin in the pathogenesis of rheumatoid arthritis.



    		+-nlAnn N Y Acad Sci 1209(-):91-8 (2010)
    1412007Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?



    		+-nlRheumatology (Oxford) 46(5):725-6 (2007)
    1422007Dose escalation of the anti-TNF-alpha agents in patients with rheumatoid arthritis. A systematic review.



    		+-nlRheumatology (Oxford) 46(3):529-32 (2007)
    1432005Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.



    		+-nlRheumatology (Oxford) 44(3):280-6 (2005)
    1442008Interleukin-7 in rheumatoid arthritis.



    		+-nlRheumatology (Oxford) 47(6):753-9 (2008)
    1452008Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis.



    		+-nlRheumatology (Oxford) 47(4):392-8 (2008)
    1462008Hypertension in rheumatoid arthritis.



    		+-nlRheumatology (Oxford) 47(9):1286-98 (2008)
    1472008Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future.



    		+-nlRheumatology (Oxford) 47(10):1461-8 (2008)
    1482008Fractalkine in rheumatoid arthritis: a review to date.



    		+-nlRheumatology (Oxford) 47(10):1446-51 (2008)
    1492008Assessment of anti-TNF-alpha efficacy in rheumatoid arthritis: is 3 months sufficient?



    		+-nlRheumatology (Oxford) 47(7):1073-6 (2008)
    1502005Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy.



    		+-nlRheumatology (Oxford) 44(6):721-8 (2005)
    1512005Hand surgery in rheumatoid arthritis: state of the art and suggestions for research.



    		+-nlRheumatology (Oxford) 44(7):834-45 (2005)
    1522011Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.



    		+-nlHealth Technol Assess 15(14):1-278 (2011)
    1532010Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.



    		+-nlHealth Technol Assess 14(Suppl. 2):1-10 (2010)
    1542009Rituximab for the treatment of rheumatoid arthritis.



    		+-nlHealth Technol Assess 13 Suppl 2(-):23-9 (2009)
    1552006Methotrexate in rheumatoid arthritis.



    		+-nlPharmacol Rep 58(4):473-92 (2006)
    1562010Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.



    		+-nlImmunol Rev 233(1):233-55 (2010)
    1572010The role of T helper type 17 cells in inflammatory arthritis.



    		+-nlClin Exp Immunol 159(3):225-37 (2010)
    1582006Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?



    		+-nlJ Rheumatol 33(12):2369-71 (2006) Bell DA
    1592010Matching therapy to body rhythms: an endocrine approach to treating rheumatoid arthritis.



    		+-nlJ Rheumatol 37(10):1981-2 (2010) Silverman MN
    1602005Discovering that B cells are important in rheumatoid arthritis.



    		+-nlJ Rheumatol 32(11):2067-9 (2005)
    1612004Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus.



    		+-nlJ Rheumatol 31(3):419-21 (2004)
    1622004The joy of citrulline: new insights into the diagnosis, pathogenesis, and treatment of rheumatoid arthritis.



    		+-nlJ Rheumatol 31(8):1471-3 (2004)
    1632004Mechanisms of erosion in rheumatoid arthritis.



    		+-nlJ Rheumatol 31(7):1229-37 (2004)
    1642005Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.



    		+-nlJ Rheumatol 32(1):11-16 (2005)
    1652007All patients with rheumatoid arthritis should receive corticosteroids as part of their management.



    		+-nlJ Rheumatol 34(4):656-60 (2007)
    1662007N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?



    		+-nlJ Rheumatol 34(2):250-2 (2007)
    1672008What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?



    		+-nlJ Rheumatol 35(10):1903-5 (2008) Bobbio-Pallavicini F
    1682008Collagen of articular cartilage: the neglected autoantigen of rheumatoid arthritis.



    		+-nlJ Rheumatol 35(5):731-3 (2008) Mackay IR
    1692011Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis.



    		+-nlMol Med 17(9-10):937-48 (2011)
    1702011HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis.



    		+-nlMol Med 17(5-6):397-403 (2011)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.